V600E BRAF Mutation in Vulvovaginal Melanoma Is Rare: A Study of Anti-Human BRAF V600E Monoclonal Antibody in 24 Cases

被引：0
|
作者：
Ramineni, M. [1 ]
Malpica, A. [1 ]
Luthra, R. [1 ]
Deavers, M. T. [1 ]
Euscher, E. D. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
LABORATORY INVESTIGATION | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1222
引用
收藏
页码：293A / 293A
页数：1
相关论文
共 50 条
  • [41] BRAF Mutation (V600E) Prevalence in Mexican Patients Diagnosed with Melanoma
    Denise Zepeda-Lopez, Priscilla
    Cesar Salas-Alanis, Julio
    Toussaint-Caire, Sonia
    Gutierrez-Mendoza, Daniela
    Vega-Memije, Elisa
    Lino Silva, Saul
    Raul Fajardo-Ramirez, Oscar
    Alcazar, Gregorio
    Guadalupe Moreno-Trevino, Mara
    Barrera Saldana, Hugo Alberto
    CASE REPORTS IN ONCOLOGY, 2016, 9 (01): : 241 - 245
  • [42] BRAF V600E mutation in thyroid nodules in Argentina
    Ilera, Veronica
    Dourisboure, Ricardo
    Colobraro, Antonio
    Silva Croome, Maria Del Carmen
    Olstein, Gustavo
    Gauna, Alicia
    MEDICINA-BUENOS AIRES, 2016, 76 (04) : 223 - 229
  • [43] Value of immunohistochemistry for detection of BRAF V600E mutation
    Kern, I.
    Vlacic, G.
    VIRCHOWS ARCHIV, 2020, 477 : S361 - S361
  • [44] Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody
    David Capper
    Matthias Preusser
    Antje Habel
    Felix Sahm
    Ulrike Ackermann
    Genevieve Schindler
    Stefan Pusch
    Gunhild Mechtersheimer
    Hanswalter Zentgraf
    Andreas von Deimling
    Acta Neuropathologica, 2011, 122 : 11 - 19
  • [45] Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody
    Capper, David
    Preusser, Matthias
    Habel, Antje
    Sahm, Felix
    Ackermann, Ulrike
    Schindler, Genevieve
    Pusch, Stefan
    Mechtersheimer, Gunhild
    Zentgraf, Hanswalter
    von Deimling, Andreas
    ACTA NEUROPATHOLOGICA, 2011, 122 (01) : 11 - 19
  • [46] Management of V600E and V600K BRAF-Mutant Melanoma
    Alexandra M. Haugh
    Douglas B. Johnson
    Current Treatment Options in Oncology, 2019, 20
  • [47] Management of V600E and V600K BRAF-Mutant Melanoma
    Haugh, Alexandra M.
    Johnson, Douglas B.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (11)
  • [48] Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma
    Fedorenko, Inna V.
    Paraiso, Kim H. T.
    Smalley, Keiran S. M.
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (03) : 201 - 209
  • [49] Validation of the VE1 immunostain for the BRAF V600E mutation in melanoma
    Pearlstein, Michelle V.
    Zedek, Daniel C.
    Ollila, David W.
    Treece, Amanda
    Gulley, Margaret L.
    Groben, Pamela A.
    Thomas, Nancy E.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2014, 41 (09) : 724 - 732
  • [50] BRAF overexpression is associated with BRAF V600E mutation in papillary thyroid carcinomas
    da Silva, R. C.
    de Paula, H. S. C.
    Leal, C. B. Q. S.
    Cunha, B. C. R.
    de Paula, E. C.
    Alencar, R. C. G.
    Meneghini, A. J.
    Silva, A. M. T. C.
    Gontijo, A. P.
    Wastowski, I. J.
    Saddi, V. A.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02) : 5065 - 5075
12345